Gareth Asten
Co-Founder and Managing Partner @ Acre Venture Partners
Los Angeles, United States
Gareth Asten is a Co-Founder and Managing Partner at Acre Venture Partners.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 44%
Last updated:
For AI agents: llms.txt
Industries Gareth Asten invests in
Stages Gareth Asten invests in
Countries Gareth Asten invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (44%)
- Biotechnology 3 (33%)
- Food and Beverage 3 (33%)
- DIY 1 (11%)
- AgTech 1 (11%)
Stage
- Series A 3 (33%)
- Series C 2 (22%)
- Pre-Seed 1 (11%)
- Series B 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States. | $27M / Series A / Dec 12, 2024 | ||
| Switch Bioworks produces sustainable nitrogen fertilizer by reprogramming naturally occurring symbiotic microbes to produce fertilizers. | $4.3M / Pre-Seed / May 25, 2022 | ||
| BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States. | $12M / Series A / Apr 13, 2022 | ||
| UR Labs is a consumer health and food tech company that focuses on nutrition solutions to address chronic health conditions. The company’s first product line launched in May 2020 and started with a meal replacement shake. It is named Muniq in honor of Washington’s late sister, Monica, who suffered from diabetes and chronic illnesses. Sincelaunching Muniq in May, UR Labs has experienced quicker traction than anticipated, not only financially, but in feedback from consumers that are using the products regularly. Next up, the company is working on new applications for its products, such as controlling blood sugar and weight. | $8.2M / Series A / Jan 12, 2021 | ||
| BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States. | $5M / Series A / May 13, 2020 | ||
| Evolve Biosystems is a biotechnology company that specializes in providing microbiome-based products designed to develop, restore, and maintain. The company's platform focuses on solving the gut dysbiosis throughout the human life cycle as well as in various animal species, enabling physicians to maintain the healthy gut microbiome in newborninfants with a consumer-directed home use product, and a hospital-based neonatal ICU product. | $40M / Series C / Jun 13, 2018 | ||
| The Safe + Fair Food Company is a plant-based food company that produces healthy foods for friends, communities, and family. The company's products help expand comfort and ease for food-allergic families and grow inclusive communities that come together with a shared love of food. The Safe + Fair Food Company was founded in 2012 and is basedin Chicago, IL. | $10M / Series C / Jun 29, 2017 | ||
| Evolve Biosystems is a biotechnology company that specializes in providing microbiome-based products designed to develop, restore, and maintain. The company's platform focuses on solving the gut dysbiosis throughout the human life cycle as well as in various animal species, enabling physicians to maintain the healthy gut microbiome in newborninfants with a consumer-directed home use product, and a hospital-based neonatal ICU product. | $20M / Series B / May 30, 2017 | ||
| Back to the Roots offers gardening kits to grow organic and gourmet mushrooms at homes. Founded in 2009 by Alejandro Velez and Nikhil Arora as a 100% sustainable urban mushroom farm, BTTR has transformed into a company focused on bringing sustainable grow-at-home products into households. Their Grow-at-Home Mushroom Garden is completely indoors andcan grow up to 1lb of oyster mushrooms in as little as 10 days. They provide a simple, eco-friendly, and quick way to have fresh oyster mushrooms right in the kitchen. | $10M / Series A / Apr 06, 2016 |
Co-Investors
About Acre Venture Partners
Driven by a mission to redefine food, Acre invests in companies creating systemic change in the food system to address the growing problems of human and environmental health. Acre makes venture-stage investments in highly disruptive platform businesses across the food value chain, with a particular focus on the agriculture, food tech, and consumerverticals. Taken together, these investments have the ability to form the foundation of an integrated new approach to food system evolution.
Acre Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alex Bondar
Partner
|
|||
|
Gareth Asten
Co-Founder and Managing Partner
|
|||
Samuel Kass
Partner
|
|||
Jeffrey Dunn
Co-Founder
|
|||
|
Lucas Mann
Co-Founder and Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Gareth Asten invest in?
Gareth Asten invests primarily in Health Care, Biotechnology and Food and Beverage startups, most often at Series A and Series C stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Gareth Asten?
Public channels for Gareth Asten include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Gareth Asten last invest?
The most recent investment recorded for Gareth Asten closed in Dec 2024. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
